The relationship between dietary iron and the gut microbiota. Can dietary iron regime be exploited to improve health?
The relationship between dietary iron and the gut microbiota. Can dietary iron regime be exploited to improve health?
批准号:
BB/N021800/1
负责人:
Simon C Andrews
金额:
$64.53万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The adult human gut is home to ~100 trillion microbes collectively known as the 'microbiota'. The gut microbiota is largely composed of bacteria and plays a key role in maintaining our wellbeing. The microbiota assists in processing food into favourable energy sources that sustain our health, and it also generates essential vitamins (e.g. vitamin K, folate, biotin), protects against gut infections and contributes to the development of our immune system. Over 1000 different types of bacteria reside within the gut, but composition varies between individuals and is subject to change. Importantly, it is now clear that alterations in our microbiota are linked to various diseases, e.g. allergy, anorexia, autism, Coeliac's disease, Crohn's disease/Ulcerative Colitis (IBD), obesity and diabetes. However, the manner in which disease state is influenced by our microbiota is poorly understood, as is the way in which diet affects the composition of our gut microbiota to influence disease.Iron is a minor yet crucial dietary component required by virtually all lifeforms. Iron deficiency in humans is the most common form of malnutrition causing iron-deficiency anaemia (IDA) affecting ~2.4 million adults and ~2.3 million children in the UK alone. IDA causes fatigue, poor concentration, weakened immunity and poor performance at school and work - representing a major economic and societal burden. IDA is treated by oral iron supplements and incidence may be reduced by iron fortification (e.g. white flour). However, iron supplements often cause undesirable gastrointestinal side-effects (nausea, abdominal pain, constipation, diarrhoea). In addition, there is mounting evidence demonstrating that dietary iron influences composition of the microbiota, with iron supplementation causing deleterious reductions in levels of beneficial commensals. Such changes are negative indicators of gut health. Indeed, extra iron provision in the diet can promote growth of pathogenic enterobacteria which may in turn provoke debilitating infectious diarrhoea. Currently, it is not clear how iron enhances these populations and diminishes the protective resident microbiota, nor is it understood how dietary iron influences the gut microbiota in general. However, it is likely that a major component of such iron-induced alterations in the microbiota is due to differences in the way in which the distinct types of bacteria within our gut respond to iron. Unfortunately, the relationship between dietary iron, gut microbiota and health/disease remains little explored, and so the potential for positive manipulation of the gut microbiota through dietary-iron regime cannot yet be exploited to promote our health and combat disease.This project will employ controlled in vitro models of our large intestine (where most gut microbiota reside) and human trials to investigate how the composition and metabolic activity of the microbiota are influenced by iron, and the impact that this has on health-related outcomes. We will explore different iron sources as well as dietary components that enhance or decrease iron availability. The ability of prebiotics to reverse unfavourable iron-induced alterations in the gut microbiota will also be investigated. In addition, the impact of iron on the gut microbiota during weaning will be examined, as this crucial period involves a dramatic increase in dietary iron content and availability, along with major changes in the gut microbiome. Increases in dietary-iron provision may be key in the development of an 'adult'-like microbiota upon weaning, a possibility that remains unexplored. We will thus shed new light on the relationship between our microbiota, and diet & health, allowing us to inform key interest groups such as nutritional scientists, the food & drink industry, government and the general public so that the effects of dietary iron on the status of our microbiota can be incorporated into current thinking to improve health.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3389/fnut.2022.927754
发表时间:
2022
期刊:
FRONTIERS IN NUTRITION
影响因子:
5
作者:
[Abbas, Munawar, Hayirli, Zeynep, Drakesmith, Hal, Andrews, Simon C. C., Lewis, Marie C. C.]
通讯作者:
Lewis, Marie C. C.
Obesity, diabetes and zinc: A workshop promoting knowledge and collaboration between the UK and Israel, november 28-30, 2016 - Israel.
肥胖、糖尿病和锌:促进英国和以色列之间的知识和合作的研讨会,2016 年 11 月 28 日至 30 日 - 以色列。
DOI:
10.1016/j.jtemb.2018.04.021
发表时间:
2018
期刊:
organ of the Society for Minerals and Trace Elements (GMS)
影响因子:
--
作者:
[Jenkins A]
通讯作者:
Jenkins A
DOI:
10.1016/j.medj.2020.10.004
发表时间:
2021-02-12
期刊:
Med (New York, N.Y.)
影响因子:
--
作者:
[Frost JN, Tan TK, Abbas M, Wideman SK, Bonadonna M, Stoffel NU, Wray K, Kronsteiner B, Smits G, Campagna DR, Duarte TL, Lopes JM, Shah A, Armitage AE, Arezes J, Lim PJ, Preston AE, Ahern D, Teh M, Naylor C, Salio M, Gileadi U, Andrews SC, Dunachie SJ, Zimmermann MB, van der Klis FRM, Cerundolo V, Bannard O, Draper SJ, Townsend ARM, Galy B, Fleming MD, Lewis MC, Drakesmith H]
通讯作者:
Drakesmith H
Characterization of bacteriocin related genes discovered in a novel probiotic isolate Enterococcus faecium W1
在新型益生菌分离株屎肠球菌 W1 中发现的细菌素相关基因的特征
DOI:
10.1099/acmi.ac2020.po0370
发表时间:
2020
期刊:
Access Microbiology
影响因子:
--
作者:
[Aziz F]
通讯作者:
Aziz F
DOI:
10.3389/fmicb.2020.584986
发表时间:
2020
期刊:
Frontiers in microbiology
影响因子:
5.2
作者:
[Baron F, Cochet MF, Alabdeh M, Guérin-Dubiard C, Gautier M, Nau F, Andrews SC, Bonnassie S, Jan S]
通讯作者:
Jan S
共 6 条
Iron mobilisation in the bacterial cell
-
批准号:BB/D002435/1
-
项目类别:Research Grant
-
资助金额:$26.79万
-
财政年份:2006
-
负责人:Simon C Andrews
-
依托单位:
海外基金